Cell‐specific elevation of NRF2 and sulfiredoxin‐1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non‐specific interstitial pneumonia

Mazur W, Lindholm P, Vuorinen K, Myllärniemi M, Salmenkivi K, Kinnula VL. Cell‐specific elevation of NRF2 and sulfiredoxin‐1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non‐specific interstitial pneumonia. APMIS 2010; 118: 703–12.

[1]  S. Biswal,et al.  Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. , 2009, Free radical biology & medicine.

[2]  J. Keski‐Oja,et al.  Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. , 2008, Antioxidants & redox signaling.

[3]  S. Kang,et al.  Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[4]  Y. Soini,et al.  Cell-specific regulation of gamma-glutamylcysteine synthetase in human interstitial lung diseases. , 2004, Human pathology.

[5]  R. Kairalla,et al.  Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP) , 2001, Journal of clinical pathology.

[6]  C. Marsh,et al.  The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. , 2008, Antioxidants & redox signaling.

[7]  T. Oury,et al.  Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. , 2005, American journal of respiratory and critical care medicine.

[8]  K. Raivio,et al.  Expression of antioxidant enzymes in human inflammatory cells. , 2000, American journal of physiology. Cell physiology.

[9]  V. Pulkkinen,et al.  Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype , 2007, The Journal of pathology.

[10]  J. Horowitz,et al.  Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  A. Holmgren,et al.  Expression of the thioredoxin system in interstitial lung disease , 2003, The Journal of pathology.

[12]  R. Crystal,et al.  Normal alveolar epithelial lining fluid contains high levels of glutathione. , 1987, Journal of applied physiology.

[13]  J. Crapo,et al.  Superoxide dismutases in the lung and human lung diseases. , 2003, American journal of respiratory and critical care medicine.

[14]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[15]  A. Holmgren,et al.  Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. , 2004, Human pathology.

[16]  P. Barnes,et al.  Exhaled markers of pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[17]  C. Ruppert,et al.  Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. , 2009, Antioxidants & redox signaling.

[18]  P. Pääkkö,et al.  Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. , 2000, American journal of respiratory and critical care medicine.

[19]  Y. Soini,et al.  Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia , 2006, Histopathology.

[20]  Y. Soini,et al.  Expression and regulation of hemeoxygenase 1 in healthy human lung and interstitial lung disorders. , 2001, Human pathology.

[21]  S. Reddy,et al.  The transcription factor NRF2 protects against pulmonary fibrosis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  M. Selman,et al.  Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2001, Respiratory research.

[23]  Deepti Malhotra,et al.  Decline in Nrf2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, Dj-1 , 2022 .

[24]  E. Bargagli,et al.  Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis , 2005, Proteomics.

[25]  Irina Petrache,et al.  Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. , 2004, The Journal of clinical investigation.

[26]  J. Crapo,et al.  Generation and disposal of reactive oxygen metabolites in the lung. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[27]  Y. Soini,et al.  Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. , 2002, American journal of clinical pathology.

[28]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[29]  Kap-Seok Yang,et al.  Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid , 2003, Journal of Biological Chemistry.

[30]  S. Ohlmeier,et al.  Peroxiredoxin II Expression and Its Association With Oxidative Stress and Cell Proliferation in Human Idiopathic Pulmonary Fibrosis , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  Hye-Youn Cho,et al.  Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. , 2008, Antioxidants & redox signaling.

[32]  K. Kuwano,et al.  Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias , 2003, European Respiratory Journal.

[33]  Rakesh K. Kumar.  Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder , 2002, Respiratory Research.

[34]  A. Flahault,et al.  Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. , 1999, American journal of respiratory cell and molecular biology.

[35]  R. Crystal,et al.  Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. , 1989, The American review of respiratory disease.